| |
|
|
|
Entera Bio Ltd.  
|
|
2.3216 -0.558 (-0.19%) |
10-16 12:41 |
|
Open: |
2.52 |
Pre close: |
2.88 |
Target:
|
3.18
|
|
High: |
2.8 |
Low: |
2.29 |
Resistance:
|
2.72
3.25
|
|
Volume: |
23,775 |
Market Cap: |
28M |
Support:
|
1.87
1.56
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
2.44
 |
MACD |
MACD(12,26):
|
-0.07  |
|
MA(20): |
2.44 |
Signal(12,26,9): |
-0.09 |
|
MA(100): |
3.01 |
Stochastic Oscillator |
%K(14,3):
|
48.11 |
|
MA(250): |
3.81 |
%D(3): |
57.61 |
|
Average Volume(K) |
3-Month: |
811
|
52-Week |
High:
|
6.40 |
|
10-Days: |
562 |
Low: |
1.35 |
|
RSI |
RSI(14):
|
45.77 |
Change(%): |
-58.7 |
|
Financials, Statistics and Valuation |
|
EPS |
-1.049 |
Return on Equity (ttm) |
0.0 |
Shares Out. (M) |
11.98 |
|
EPS Est. Current Year |
0.000 |
Return on Assets (ttm) |
-75.0 |
Shares Float (M) |
1.00 |
|
EPS Est. Next Year |
0.000 |
PEG Ratio |
0.00 |
% Held by Insiders |
46.55 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
14.27 |
|
Forward EPS |
0.000 |
Gross Profit (p.s.) |
0.042 |
Shares Short (K) |
6 |
|
Book Value (p.s.) |
0.540 |
EBITDA (p.s.) |
-0.866 |
P/E |
-2.21 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
4.30 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-8.65 |
P/S |
556255360.00 |
|
Operating Margin |
-1823.87 |
Levered Free Cash Flow
(M) |
-4.77 |
P/CF |
-3.22 |
|
|
|
|
|
|
